The risks of blood clots are much lower than the risks of COVID-19 illness, hospitalizations, and deaths. The U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) issued a statement today "recommending a pause in the use" of Johnson & Johnson's COVID-19 vaccine.